Literature DB >> 9351378

Risk of coronary heart disease and activation of factor XII in middle-aged men.

G J Miller1, M P Esnouf, A I Burgess, J A Cooper, J P Mitchell.   

Abstract

Increased activity is known to be present in the extrinsic, intrinsic, and final common pathways of the hemostatic system in men at high risk of coronary heart disease (CHD), but the status of the contact system of coagulation in this condition is uncertain. Plasma levels of activated factor XII (XIIa), the initial product of contact activation, have therefore been measured by ELISA in 2464 men aged 51 to 62 years, clinically free of CHD, who were taking part in a prospective cardiovascular survey based in general medical practices. Statistically significant, independent, and positive associations of XIIa were found with serum cholesterol and triglyceride concentrations, blood pressure, body mass index, factor VII activity, plasma fibrinogen concentration, and tobacco smoking, all associated with CHD. Plasma XIIa also increased with recent alcohol intake. Men in the highest quintile of risk according to their conventional risk factors had a mean XIIa of 2.07 ng/mL (95% confidence interval 1.99-2.16), 31% higher than that of men in the lowest quintile (1.58; 95% confidence interval 1.51-1.65). Thus, the contact system of coagulation appears to be activated when CHD risk is increased. Furthermore, the independent associations of XIIa with the major conventional CHD risk factors and its broad range of values in the general population (0.1 to 12.5 ng/mL), combined with a relatively low day-to-day variability in individuals (the within-person component of its total variation being 14.7%), suggest its potential usefulness as a marker of atherosclerotic vascular damage.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9351378     DOI: 10.1161/01.atv.17.10.2103

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  10 in total

1.  Effects of lead and mercury on the blood proteome of children.

Authors:  Robert E Birdsall; Michael P Kiley; Zaneer M Segu; Christopher D Palmer; Milan Madera; Brooks B Gump; James A MacKenzie; Patrick J Parsons; Yehia Mechref; Milos V Novotny; Kestutis G Bendinskas
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

2.  Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding.

Authors:  Alexey S Revenko; Dacao Gao; Jeff R Crosby; Gourab Bhattacharjee; Chenguang Zhao; Chris May; David Gailani; Brett P Monia; A Robert MacLeod
Journal:  Blood       Date:  2011-08-05       Impact factor: 22.113

3.  Factor XIIa and triacylglycerol rich lipoproteins: responses to exercise intervention.

Authors:  K Woolf-May; W Jones; E M Kearney; R C Davison; S Bird
Journal:  Br J Sports Med       Date:  2000-08       Impact factor: 13.800

4.  A history of late and very late stent thrombosis is not associated with increased activation of the contact system, a case control study.

Authors:  Volker Pönitz; José W Govers-Riemslag; Hugo Ten Cate; Rene van Oerle; Trygve Brügger-Andersen; Heidi Grundt; Patrycja Næsgaard; David Pritchard; Alf I Larsen; Dennis W Nilsen
Journal:  Thromb J       Date:  2010-04-15

Review 5.  Humoral innate immune response and disease.

Authors:  Stephanie N Shishido; Sriram Varahan; Kai Yuan; Xiangdong Li; Sherry D Fleming
Journal:  Clin Immunol       Date:  2012-06-18       Impact factor: 3.969

6.  Defective thrombus formation in mice lacking coagulation factor XII.

Authors:  Thomas Renné; Miroslava Pozgajová; Sabine Grüner; Kai Schuh; Hans-Ulrich Pauer; Peter Burfeind; David Gailani; Bernhard Nieswandt
Journal:  J Exp Med       Date:  2005-07-11       Impact factor: 14.307

7.  F12 as a reliable diagnostic and prognostic biomarker associated with immune infiltration in papillary thyroid cancer.

Authors:  Jun-Hua Luo; Xiu-Xia Zhang; Wu-Hui Sun
Journal:  Aging (Albany NY)       Date:  2022-04-28       Impact factor: 5.682

8.  Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes.

Authors:  Naoto Katakami; Mitsuyoshi Takahara; Hideaki Kaneto; Ikki Shimizu; Keizo Ohno; Fukashi Ishibashi; Takeshi Osonoi; Atsunori Kashiwagi; Ryuzo Kawamori; Iichiro Shimomura; Munehide Matsuhisa; Yoshimitsu Yamasaki
Journal:  Diabetes Care       Date:  2009-11-23       Impact factor: 19.112

9.  Circulating contact-pathway-activating microparticles together with factors IXa and XIa induce spontaneous clotting in plasma of hematology and cardiologic patients.

Authors:  Elena Lipets; Olga Vlasova; Evdokiya Urnova; Oleg Margolin; Anna Soloveva; Olga Ostapushchenko; John Andersen; Fazoil Ataullakhanov; Mikhail Panteleev
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

10.  Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study.

Authors:  Kristina Johansson; Jan-Håkan Jansson; Lars Johansson; Ingemar Bylesjö; Torbjörn K Nilsson; Mats Eliasson; Stefan Söderberg; Marcus Lind
Journal:  Cerebrovasc Dis Extra       Date:  2017-04-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.